Five Prime Therapeutics Inc (NASDAQ:FPRX)

18.34
Delayed Data
As of Feb 16
 -0.41 / -2.19%
Today’s Change
17.05
Today|||52-Week Range
49.30
-16.33%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close18.75
Today’s open18.63
Day’s range18.30 - 19.11
Volume324,107
Average volume (3 months)623,470
Market cap$623.8M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-126.44%
Earnings growth (this year)-127.55%
Earnings growth (next 5 years)--
Revenue growth (last year)-91.92%
P/E ratioNM
Price/Sales44.01
Price/Book1.29

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.50-2.68%
----
RTRXRetrophin Inc+0.54+2.43%
EDITEditas Medicine Inc-0.97-2.79%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 27, 2018
EPS forecast (this quarter)-$1.23
Annual revenue (last year)$30.7M
Annual profit (last year)-$65.7M
Net profit margin-214.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Aron M. Knickerbocker
Chief Financial Officer &
Senior Vice President
Marc L. Belsky
Corporate headquarters
South San Francisco, California

Forecasts